Abstract
Purpose
The present study evaluated the clinical results of phototherapeutic keratectomy (PTK) for refractory recurrent corneal erosion (RCE).
Methods
A total of 12 eyes from 11 RCE patients who had been initially treated with conservative therapy but suffered from recurrence, were treated using PTK with 193 nm excimer laser. The preoperative and postoperative best corrected visual acuity (BCVA), spherical equivalent, average keratometric value, re-epithelialization time, corneal haze, complications and recurrence were investigated.
Results
PTK was combined with photorefractive keratectomy in 1 eye. The mean follow-up time was 11.42 months. All 12 eyes were successfully treated and had no recurrence during the follow-up except 1 eye where the symptoms recurred 9 months postoperatively. Postoperative BCVAs were all better than the preoperative BCVAs. Mild myopic change (average -0.20 diopter) and increased average keratometric values (average 0.27 diopter) were noted in 11 eyes which were treated using PTK alone. The average re-epithelialization time was 5.63 days. No specific complication except mild corneal haze was found.
Go to : 

References
1. Reidy JJ, Paulus MP, Gona S. Recurrent erosions of the cornea: epidemiology and treatment. Cornea. 2000; 19:767–71.
2. Lee SH, Kim TI, Chung SH, et al. A case of combined bacterial keratitis with recurrent corneal erosion. J Korean Ophthalmol Soc. 2007; 48:449–54.
3. Han MS, Lee JH, Lee SJ. Therapeutic effect of topical autologous serum in recurrent punctate corneal erosion. J Korean Ophthalmol Soc. 2004; 45:1639–44.
4. Suh Y, Kim MS. The longterm evaluation of recurrent corneal erosion. J Korean Ophthalmol Soc. 2002; 43:1570–6.
5. Benitez-Del-Castillo JM, Rodríguez-Bayo S, Fontan-Rivas E, et al. Treatment of recurrent corneal erosion with substance P-de-rived peptide and insulin-like growth factor I. Arch Ophthalmol. 2005; 123:1445–7.


6. Dursun D, Kim MC, Solomon A, Pflugfelder SC. Treatment of re-calcitrant recurrent corneal erosions with inhibitors of matrix met-alloproteinase-9, doxycycline and corticosteroids. Am J Ophthalmol. 2001; 132:8–13.


7. Wang L, Tsang H, Coroneo M. Treatment of recurrent corneal erosion syndrome using the combination of oral doxycycline and topical corticosteroid. Clin Experiment Ophthalmol. 2008; 36:8–12.


8. Galbavy EJ, Mobilia EF, Kenyon KR. Recurrent corneal erosions. Int Ophthalmol Clin. 1984; 24:107–31.


9. Trobe JD, Laibson PR. Dystrophic changes in the anterior cornea. Arch Ophthalmol. 1972; 87:378–82.


10. Buxton JN, Constad WH. Superficial epithelial keratectomy in the treatment of epithelial basement membrane dystrophy. Ann Ophthalmol. 1987; 19:92–6.


11. Hsu JK, Rubinfeld RS, Barry P, Jester JV. Anterior stromal puncture. Immunohistochemical studies in human corneas. Arch Ophthalmol. 1993; 111:1057–63.
12. Lee SW, Choi TH. Anterior stromal puncture with 26-gauge needle for recurrent corneal erosion: A report of five cases. J Korean Ophthalmol Soc. 2003; 44:511–6.
13. Soong HK, Farjo Q, Meyer RF, Sugar A. Diamond burr superficial keratectomy for recurrent corneal erosions. Br J Ophthalmol. 2002; 86:296–8.


14. Wong VW, Chi SC, Lam DS. Diamond burr polishing for recurrent corneal erosions: results from a prospective randomized controlled trial. Cornea. 2009; 28:152–6.


15. Hodkin MJ, Jackson MN. Amoils epithelial scrubber to treat recurrent corneal erosions. J Cataract Refract Surg. 2004; 30:1896–901.


16. Trokel SL, Srinivasan R, Braren B. Excimer laser surgery of the cornea. Am J Ophthalmol. 1983; 96:710–5.


17. Park JW, Kim JH. Phototherapeutic keratectomy for granular corneal dystrophy. J Korean Ophthalmol Soc. 2003; 44:2465–72.
18. Campos M, Nielsen S, Szerenyi K, et al. Clinical follow-up of phototherapeutic keratectomy for treatment of corneal opacities. Am J Ophthalmol. 1993; 115:433–40.


19. Stark WJ, Chamon W, Kamp MT, et al. Clinical follow-up of 193-nm ArF excimer laser photokeratectomy. Ophthalmology. 1992; 99:805–12.


20. Fagerholm P, Fitzsimmons TD, Orndahl M, et al. Phototherapeutic keratectomy: long-term results in 166 eyes. Refract Corneal Surg. 1993; 9:S76–81.


21. Rapuano CJ, Laibson PR. Excimer laser phototherapeutic keratectomy for anterior corneal pathology. CLAO J. 1994; 20:253–7.


22. Zuckerman SJ, Aquavella JV, Park SB. Analysis of the efficacy and safety of excimer laser PTK in the treatment of corneal disease. Cornea. 1996; 15:9–14.


23. Rapuano CJ. Excimer laser phototherapeutic keratectomy: long-term results and practical considerations. Cornea. 1997; 16:151–7.
24. Förster W, Atzler U, Ratkay I, Busse H. Therapeutic use of the 193-nm excimer laser in corneal pathologies. Graefes Arch Clin Exp Ophthalmol. 1997; 235:296–305.


25. Sher NA, Bowers RA, Zabel RW, et al. Clinical use of the 193-nm excimer laser in the treatment of corneal scars. Arch Ophthalmol. 1991; 109:491–8.


26. Lawless MA, Cohen P, Rogers C. Phototherapeutic keratectomy for Reis-Bückler's dystrophy. Refract Corneal Surg. 1993; 9:S96–8.


27. Lee SB, Lee JG, Hahn DK. A clinical experience of phototherapeutic keratectomy for Reis-Bucklers' dystrophy. J Korean Ophthalmol Soc. 1996; 37:365–70.
28. Lim MY, Sah WJ, Hahn TW, Kim JH. A Case of Reis-Buckler's dystrophy treated with excimer laser phototherapeutic keratectomy. J Korean Ophthalmol Soc. 1994; 35:1498–503.
29. Song SW, Kim MS. Phototherapeutic keratectomy for the treatment of persistent epithelial defect. J Korean Ophthalmol Soc. 1997; 38:1348–54.
30. Ko BY. Phototherapeutic keratectomy for refractory recurrent corneal erosion. Konyang Med J. 2008; 8:69–74.
31. Gipson IK, Spurr-Michaud SJ, Tisdale AS. Anchoring fibrils form a complex network in human and rabbit cornea. Invest Ophthalmol Vis Sci. 1987; 28:212–20.
32. Wood TO, Judge D, Payant J, Frase S. Electron microscopy of anterior stromal micropuncture. Invest Ophthalmol Vis Sci. 1989; 30:1.
33. Yoo JW, Chung JH, Lee HR. Effects of topically applied autologous serum on experimental corneal epithelial healing following alkali wounds. J Korean Ophthalmol Soc. 1998; 39:2003–12.
34. Khodadoust AA, Silverstein AM, Kenyon DR, Dowling JE. Adhesion of regenerating corneal epithelium. The role of basement membrane. Am J Ophthalmol. 1968; 65:339–48.
35. Nishida T, Nakagawa S, Manabe R. Clinical evaluation of fi-bronectin eyedrops on epithelial disorders after herpetic keratitis. Ophthalmology. 1985; 92:213–6.


36. Nishida T, Yagi J, Fukuda M, et al. Spontaneous persistent epithelial defects after cataract surgery. Cornea. 1987; 6:32–7.


37. Shapiro MS, Friend J, Thoft RA. Corneal re-epithelialization from the conjunctiva. Invest Ophthalmol Vis Sci. 1981; 21:135–42.
38. Lee SW, Choi TH. Anterior stromal puncture with 26-gauge needle for recurrent corneal erosion: A report of five cases. J Korean Ophthalmol Soc. 2003; 44:511–6.
39. McLean EN, MacRae SM, Rich LF. Recurrent erosion. Treatment by anterior stromal puncture. Ophthalmology. 1986; 93:784–8.
40. Geggel HS. Successful treatment of recurrent corneal erosion with Nd:YAG anterior stromal puncture. Am J Ophthalmol. 1990; 110:404–7.


41. Katz HR, Snyder ME, Green WR, et al. Nd:YAG laser photo-in-duced adhesion of the corneal epithelium. Am J Ophthalmol. 1994; 118:612–22.


42. Hwang JH, Im JS, Kim EK, Hong SB. Therapeutic effect of recurrent corneal erosion by Nd: YAG anterior stromal puncture. J Korean Ophthalmol Soc. 1998; 39:1319–25.
43. Ewald M, Hammersmith KM. Review of diagnosis and management of recurrent erosion syndrome. Curr Opin Ophthalmol. 2009; 20:287–91.


45. Jain S, Austin DJ. Phototherapeutic keratectomy for treatment of recurrent corneal erosion. J Cataract Refract Surg. 1999; 25:1610–4.


46. O'Brart DP, Muir MG, Marshall J. Phototherapeutic keratectomy for recurrent corneal erosions. Eye (Lond). 1994; 8:378–83.
47. Cavanaugh TB, Lind DM, Cutarelli PE, et al. Phototherapeutic keratectomy for recurrent erosion syndrome in anterior basement membrane dystrophy. Ophthalmology. 1999; 106:971–6.
48. Seitz B, Langenbucher A, Hafner A, et al. Phototherapeutic keratectomy for recurrent corneal erosion syndrome (e-PTK). Report on 116 consecutive interventions. Ophthalmologe. 2002; 99:703–8.
49. Morad Y, Haviv D, Zadok D, et al. Excimer laser phototherapeutic keratectomy for recurrent corneal erosion. J Cataract Refract Surg. 1998; 24:451–5.


50. Dinh R, Rapuano CJ, Cohen EJ, Laibson PR. Recurrence of corneal dystrophy after excimer laser phototherapeutic keratectomy. Ophthalmology. 1999; 106:1490–7.
Go to : 

Table 1.
Clinical characteristics of cases
Case No. | Sex/Age (yr) | Cause of RCE* | Symptoms | Frequency and duration (No./mon) | Previous treatment | Response to PTK† | Follow up period (mon) |
---|---|---|---|---|---|---|---|
1 | M/45 | Idiopathic | Ocular pain, blurred vision, epiphora, conjunctival injection | 4/7 | Patching, contact lens, antibiotics, lubricants, hyperosmotics, debridement | No recurrence | 24 |
2 | M/47 | Trauma (plant) | Ocular pain, blurred vision, epiphora, photophobia, foreign body sensation, conjunctival injection | 2/13 | Contact lens, antibiotics, lubricants, hyperosmotics, debridement | No recurrence | 2 |
3 | F/49 | Idiopathic | Ocular pain, foreign body sensation | 2/2 | Contact lens, antibiotics, lubricants, hyperosmotics | No recurrence | 6 |
4 | F/43 | Trauma (paper cut) | Ocular pain | 4/13 | Contact lens, antibiotics, lubricants, hyperosmotics, autologous serum | No recurrence | 12 |
5 | M/20 | Alport’s syndrome | Ocular pain, blurred vision, epiphora, foreign body sensation, conjunctival injection | 5/10 | Contact lens, antibiotics, lubricants, hyperosmotics, debridement | No recurrence | 17 |
6 | M/45 | Idiopathic | Ocular pain conjunctival injection | 6/4 | Contact lens, antibiotics, lubricants, hyperosmotics, debridement | No recurrence | 3 |
7 | M/52 | Foreign body | Ocular pain foreign body sensation, | 1/2 | Contact lens, antibiotics, lubricants, hyperosmotics, debridement | No recurrence | 12 |
8 | F/37 | Trauma (box edge) | Ocular pain conjunctival injection | 8/5 | Contact lens, antibiotics, lubricants, hyperosmotics, debridement | No recurrence‡ | 15 |
9 | M/46 | Trauma (plant) | Ocular pain visual disturbance | 1/7 | Contact lens, antibiotics, lubricants, hyperosmotics, debridement | No recurrence | 12 |
10 | M/35 | Trauma (plastic) | Ocular pain conjunctival injection foreign body sensation | 4/4 | Contact lens, antibiotics, lubricants, hyperosmotics, debridement | No recurrence | 11 |
11 | M/59 | Trauma (foreign body) | Conjunctival injection foreign body sensation | 3/2 | Contact lens, antibiotics, lubricants, hyperosmotics, debridement | No recurrence | 7 |
12 | M/20 | Alport’s syndrome | Ocular pain foreign body sensation | 1/5 | Contact lens, antibiotics, lubricants, hyperosmotics, debridement | No recurrence | 16 |
Table 2.
Analysis of each treatment case
Case No. | Preoperative BCVA* | Postoperative BCVA | Preoperative SE† (D) | Postoperative SE (D) | SE change (D) | Preoperative average K (D) | Postoperative average K (D) | Average K change (D) | Ablation stromal depth (Mm) | PlanoScan PTK‡(pulse) | Joystick PTK (pulse) |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 0.3 | 1.0 | -5.50 | -4.25 | + 1.25 | 43.50 | 42.50 | -1.00 | 20 | 501(PRK§) | 191 |
2 | 0.1 | 0.8 | -6.25 | -7.00 | -0.75 | 43.75 | 45.00 | + 1.25 | 5 | 247 | 400 |
3 | 0.8 | 1.0 | -4.75 | -4.50 | +0.25 | 46.00 | 46.50 | +0.50 | 10 | 485 | 100 |
4 | 0.7 | 1.0 | -1.75 | -1.25 | +0.50 | 43.75 | 43.75 | 0 | 7 | 343 | 75 |
5 | 0.9 | 1.0 | -0.75 | -0.25 | +0.50 | 45.50 | 45.00 | -0.50 | 7 | 343 | 100 |
6 | 0.15 | 0.7 | -5.0 | -5.75 | -0.75 | 43.00 | 43.50 | +0.50 | 10 | 545 | 200 |
7 | 0.15 | 1.0 | -1.75 | -2.50 | -0.75 | 47.50 | 47.00 | -0.50 | 5 | 247 | 250 |
8 | 1.0 | 1.0 | -1.25 | -0.75 | +0.50 | 42.50 | 42.50 | 0 | 5 | 247 | 200 |
9 | 1.0 | 1.0 | -0.25 | -1.25 | -1.00 | 43.50 | 44.00 | +0.50 | 5 | 247 | 300 |
10 | 0.7 | 1.0 | -3.75 | -4.25 | -0.50 | 43.50 | 44.00 | +0.50 | 5 | 278 | 400 |
11 | 0.5 | 0.9 | -0.50 | -0.75 | -0.25 | 45.00 | 45.50 | +0.50 | 5 | 278 | 200 |
12 | 1.0 | 1.0 | -0.50 | -0.50 | 0 | 44.75 | 45.00 | +0.25 | 7 | 343 | 70 |
Table 3.
Outcome |
Group |
p-value | ||
---|---|---|---|---|
Trauma No. of eyes (%) | Corneal dystrophy No. of eyes (%) | Idiopathic No. of eyes (%) | ||
Refractive changes for PTK alone | 0.262‡ | |||
No change | 2 (29) | 1 (50) | ||
Hyperopia | 1 (14) | 1 (50) | ||
Myopia | 4 (57) | 2§ (100) | ||
Visual acuity | ||||
Changes | 0.420‡ | |||
No change | 2 (29) | 1 (50) | ||
Loss of 1 Snellen line | ||||
Gain of 1 Snellen line | 5 (71) | 1 (50) | 3 (100) | |
Re-epithelialization time (days) | 5.75 | 4.50 | 4.67 | 0.318∏ |
Follow-up range (months) | 10.67 | 16.50 | 11.00 | 0.201∏ |